Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Exendin-4, the peptide isolated from Gila monster venomous saliva, became the foundation for exenatide, the first GLP-1 receptor agonist approved by the FDA in 2005 under the brand name Byetta
The results mirror a previous observation from our group, that hypothalamic Gipr KO appeared to sensitize DIO mice to weight loss induced by a long-acting GLP-1R agonista finding that had not been the focus of that study and remained unexplained at the time but has since also been observed in global GIPR-KO mice 7,11
Many patients notice reduced wrinkles and healthier hair, resulting in a more youthful appearance
Finally, a pooled analysis of RCTs and open-label phase III studies showed that once-weekly exenatide reduced albuminuria 26% (95% CI%: 39.5 to 10%) compared with comparators (Van Der Aart-Van Der Beek et al., 2020)
US$ 20.43
US$ 23.02
US$ 26.40
US$ 26.87
